Azacitidine/Ruxolitinib Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of azacitidine and ruxolitinib that may be used in the treatment of myeloproliferative neoplasms, and atypical chronic myeloid leukemia (aCML) and chronic myelomonocytic leukemia (CMML)-2 with CSF3R or JAK2 mutation.

**Synonyms:** - 5-Azacytidine/Ruxolitinib Regimen - Azacitidine-Ruxolitinib - Azacitidine-Ruxolitinib Regimen - Azacitidine/Jakafi Regimen - Azacitidine/Ruxolitinib - Ruxolitinib/Azacitidine